UPDATE 5-AbbVie looks beyond Humira with $63 bln deal for Botox-maker Allergan
June 25, 2019 at 11:11 AM EDT
Drugmaker AbbVie Inc said on Tuesday it would buy Botox-maker Allergan Plc for about $63 billion, grabbing control of the biggest name in medical aesthetics to help reduce its reliance on blockbuster arthritis treatment Humira.
